Simler, Nadine, Alexandra Grosfeld, André Peinnequin, Michèle Guerre-Millo, and André-Xavier Bigard. Leptin receptor-deficient obese Zucker rats reduce their food intake in response to hypobaric hypoxia. Am J Physiol Endocrinol Metab 290: E591-E597, 2006. First published October 18, 2005 ; doi:10.1152/ajpendo.00289.2005.-Exposure to hypoxia induces anorexia in humans and rodents, but the role of leptin remains under discussion and that of orexigenic and anorexigenic hypothalamic neuropeptides remains unknown. The present study was designed to address this issue by using obese (Lepr fa /Lepr fa ) Zucker rats, a rat model of genetic leptin receptor deficiency. Homozygous lean (Lepr FA /Lepr FA ) and obese (Lepr fa / Lepr fa ) rats were randomly assigned to two groups, either kept at ambient pressure or exposed to hypobaric hypoxia for 1, 2, or 4 days (barometric pressure, 505 hPa). Food intake and body weight were recorded throughout the experiment. The expression of leptin and vascular endothelial growth factor (VEGF) genes was studied in adipose tissue with real-time quantitative PCR and that of selected orexigenic and anorexigenic neuropeptides was measured in the hypothalamus. Lean and obese rats exhibited a similar hypophagia (38 and 67% of initial values at day 1, respectively, P Ͻ 0.01) and initial decrease in body weight during hypoxia exposure. Hypoxia led to increased plasma leptin levels only in obese rats. This resulted from increased leptin gene expression in adipose tissue in response to hypoxia, in association with enhanced VEGF gene expression. Increased hypothalamic neuropeptide Y levels in lean rats 2 days after hypoxia exposure contributed to accounting for the enhanced food consumption. No significant changes occurred in the expression of other hypothalamic neuropeptides involved in the control of food intake. This study demonstrates unequivocally that altitude-induced anorexia cannot be ascribed to anorectic signals triggered by enhanced leptin production or alterations of hypothalamic neuropeptides involved in anabolic or catabolic pathways.
altitude; anorexia; energy balance; adipose tissue EXPOSURE TO LOW ATMOSPHERIC OXYGEN (hypoxia) at high altitude elicits a variety of adaptive responses in humans. A classical adverse response to hypobaric hypoxia is weight loss. Although weight loss may be partly accounted for by a loss of body fluids (20) , nutrient malabsorption (45) , and/or changes in protein metabolism (33) , a major determinant is decrease in food intake. During high-mountain expeditions, anorexia may occur due to stress, overexertion, or a decrease in the availability of palatable food (18) . However, humans exposed to simulated high altitude in a hypobaric chamber, in which stressful conditions are avoided, also experience a marked loss of appetite (50, 52, 53) . Thus exposure to hypoxia appears to be sufficient to alter the regulation of food intake and promote anorexia in humans.
Under normal life conditions, feeding behavior is under the tight control of multiple metabolic and hormonal signals, which are integrated in the brain to adjust food intake to the level of energy expenditure (40) . Leptin, an adipocyte-derived hormone produced in proportion to body fat stores, is a crucial component of this regulatory system. Mutations in leptin or leptin receptor gene result in massive obesity in rodents and humans, due to the lack of feedback downregulation of food intake with increasing fat mass (for review see Ref. 1). In the brain, leptin acts on hypothalamic neurons, which express its receptors, to modulate the expression of neuropeptides controlling feeding. Neuropeptide Y (NPY) and agouti-related protein (AgRP) participate in anabolic pathways by stimulating food intake. Conversely, ␣-melanocyte-stimulating hormone (␣-MSH), cleaved from proopiomelanocortin (POMC), cocaine-amphetamine-related transcript (CART), and corticotropin-releasing hormone (CRH) inhibit food intake and promote negative energy balance. These peptides are reciprocally regulated by leptin, which reduces anabolic and activates catabolic pathways (40) . Studies in rodents have demonstrated reductions in food intake in response to administration of recombinant leptin, thereby establishing firmly that leptin exerts an inhibitory effect on food intake (1). However, except for leptin-deficient individuals, most obese patients and animal models have elevated plasma concentrations of leptin, and this feature is not associated with reduced rates of food intake. Thus it is commonly admitted that obese individuals are resistant to the anorectic effect of leptin. So far, it is still unclear whether or not elevation of endogenous circulating levels of leptin inhibits food intake in normal-weight, leptin-sensitive subjects. Cell experiments from our and other laboratories have recently provided evidence that leptin gene expression and secretion are induced by hypoxia (14, 15, 23) and that the human leptin gene is a hypoxia-inducible gene via hypoxia-inducible factor-1 (HIF-1)-dependent mechanisms (2, 13) . These observations raise the hypothesis that HIF-1-stimulated leptin adipose production could be part of the mechanisms mediating the anorectic effect of hypoxia.
Whether circulating leptin levels increase in response to ambient hypoxia has been tested in vivo with conflicting results. Elevated plasma leptin has been reported in healthy individuals during acute short-term exposure to high altitude, specifically in those volunteers experiencing a loss of appetite (46) . However, in another study, gradual adaptation to high altitude induced a progressive slight decrease in circulating leptin in men (54) . A few studies have also been performed in rodents exposed to various hypoxic conditions. In mice, intermittent hypoxia produced by repeated 30-s periods of reduced oxygen (5% oxygen) increased leptin gene expression in subcutaneous adipose tissue and leptin circulating levels, although with no major change in food intake (31) . By contrast, leptin expression was virtually unchanged in the adipose tissue of adult rats after acute exposure to permanent hypoxia (25) . When young rats were submitted to normobaric hypoxia (12% oxygen) for 7 days, plasma leptin levels were significantly lower than in normoxic controls (34) . Thus, although leptin is induced by hypoxic stimuli in cellular models, no clear-cut conclusion can be drawn from in vivo observations on whether ambient hypoxia affects adipose leptin production or on the role of leptin in hypoxia-induced dysregulation of feeding.
Therefore, the present study was designed to address the role of leptin in the mediation of hypoxia-induced anorexia. To this aim, we measured adipose leptin gene expression and circulating leptin levels in adult rats exposed to a simulated altitude of 5,500 m in a hypobaric chamber. Previous experiments have established that this experimental model is well suited to investigate the mechanisms of hypoxia-induced anorexia, since the rats markedly and rapidly decrease their spontaneous food intake when exposed to hypobaric hypoxia (4, 8) . In the present study, we used obese (Lepr fa /Lepr fa ) Zucker rats, a rat model of genetic leptin receptor deficiency (6, 30) , to test directly whether hypoxia-induced anorexia was dependent on leptin signaling. This rat model was chosen because animals are resistant to the food intake-reducing effect of leptin and unable to respond to peripherally administered leptin (7, 16, 48, 49) . To avoid any confounding effect of environmental stress, care was taken to accustom the rats to hypobaric chambers before barometric pressure was reduced. In addition, we investigated whether changes in the expression of selected orexigenic and anorexigenic hypothalamic neuropeptides could account for the effect of hypoxia on feeding in the presence or absence of leptin signal.
MATERIALS AND METHODS

Animals.
Male Zucker rats (Charles River, L'Arbresle, France) were used at 2 mo of age. Homozygous lean (Lepr FA /Lepr FA ) and obese (Lepr fa /Lepr fa ) rats weighed 170 Ϯ 4 g (n ϭ 30) and 184 Ϯ 4 g (n ϭ 24), respectively, at the beginning of the experiment. This study was performed in accordance with the Helsinki agreement for the humane treatment of laboratory animals. All experiments were performed in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Council of Europe no. 129, Strasbourg, 1985) , and approved by the Animal Ethics Committee of the Centre de Recherches du Service de Sante des Armees. All animals were housed individually in hanging wire-mesh cages and were kept on an artificial 12:12-h light-dark cycle with light on at 0900. The design of these metabolism cages prevented coprophagy. Lean and obese Zucker rats were randomly assigned to two experimental groups: either kept at ambient pressure (10 lean and 9 obese rats) or exposed to hypobaric hypoxia (20 lean and 15 obese rats) for 1, 2, or 4 days. For ethical reasons, and to minimize the number of animals used, only two groups were kept at a normal atmospheric pressure to serve as controls for rats exposed to hypobaric hypoxia during 1 and 4 days.
Experimental design. Hypoxic animals were housed in a hypobaric chamber (Alsthom EY2400 Sauter, Levallois-Perret, France) and exposed to barometric pressure that was progressively reduced (30 min) until the equivalent of 5,500 m altitude was reached (i.e., barometric pressure of 505 hPa and partial oxygen pressure of 106 hPa). Ambient temperature was maintained at 22 Ϯ 2°C. The rats were exposed to hypobaric conditions at 0900 at the beginning of the light period. The chamber was opened daily for 30 min between 0900 and 1000 to refill food and water dispensers. Throughout the experimental period, rats were given free access to a standard powdered laboratory chow (AO3 UAR; Charles River) and tap water. Spillage was checked throughout the experimental conditioning and was considered negligible. Preweighed powdered food was presented at 1000, and food consumption was measured the following day at 0900 (23-h food consumption). Rats were weighed daily to monitor body weight gain, and the daily food intake was expressed either as absolute values or per 100 grams body weight.
Animals were anesthetized with halothane gas, between 0900 and 1000, after 1, 2, or 4 days of hypoxia exposure. Tail clips for genotyping were taken, and blood samples were withdrawn from the abdominal aorta into a heparin-treated syringe and collected in EDTA. Hematocrit was determined after triplicate measurements from wholeblood samples. Plasma was then separated by centrifugation and stored at Ϫ20°C until use. Retroperitoneal white adipose tissue was collected, weighed, and rapidly frozen in liquid nitrogen. The brain was removed and the hypothalamus dissected out according to the rat stereotaxic coordinates established by Paxinos and Watson (28) . Tissue samples were stored at Ϫ80°C until use.
Genotype identification. Lean rat genomic DNA was isolated from tail clips, and genotypes at the leptin receptor locus were identified as previously described (6, 40) . The genotype of each animal was established, and only homozygous animals were used.
RNA isolation and mRNA levels. Total RNA was extracted from retroperitoneal adipose tissue samples and from dissected hypothalamus. White adipose tissue cDNA was synthesized from 2 g of total RNA, using random hexamers and Superscript II reverse transcriptase (Invitrogen, Cergy, France). Hypothalamic cDNA was generated from 500 ng of total RNA with an oligo(dT) 15 primer mix and AMV reverse transcriptase (1st-strand cDNA synthesis kit for RT-PCR; Roche, Meylan, France). Real-time quantitative PCR analysis was performed, starting with 50 ng of reverse-transcribed total RNA, with 525 nM sense and antisense primers (Table 1) , in a final volume of 20 l, using the LCFast Start DNA Master SYBR Green I kit in a Light Cycler detection system (Roche Applied Science, Mannheim, Germany). Specificity was checked for each sample by melting curve analysis. Transcription levels were normalized using an internal control gene with a comparative threshold cycle method (21) by RelQuant software (Roche Applied Science). A pool of all samples was used as a calibrator, as described previously (29) . Variations in the initial quantities of cDNA were normalized by cyclophilin A mRNA amplification and quantification.
Biochemical analysis. Glucose concentrations were determined in duplicate by the glucose oxidase method (Glucose GOD-PAP; Roche Diagnostic, Meylan, France). Plasma concentrations of insulin and leptin were assessed by radioimmunoassays [Insulin-CT (Cis BioInternational, Gif sur Yvette, France) and rat leptin RIA kit (Linco Research, St. Charles, MO), respectively].
Statistical analysis. All data are expressed as means Ϯ SE. A two-way analysis of variance was processed on the raw data to assess global effects of genotype, exposure to hypoxia, and/or interaction between these two factors. When appropriate, differences between groups were tested with a Newman-Keuls post hoc test. Values of P Ͻ 0.05 were considered to be statistically significant.
RESULTS
Hematocrit.
The hematological response to reduced oxygen availability was assessed in lean and leptin receptor-deficient obese Zucker rats exposed to hypobaric hypoxia (Fig. 1) . In normoxic conditions, hematocrit values were slightly lower in obese (37.2 Ϯ 0.9%, n ϭ 9) than in lean rats (43.4 Ϯ 1.0%, n ϭ 10, P Ͻ 0.01), consistent with the implication of leptin in hematopoiesis (3). Nevertheless, hematocrit values increased gradually in both groups in response to ambient hypoxia, and on day 4 of exposure, hematocrit levels were significantly higher in hypoxic than in normoxic rats, whatever the genotype. Thus intact leptin signaling is not required for hematological adaptation to decreased oxygen availability.
Food intake. As expected, food intake was higher in normoxic obese Zucker rats than in lean rats (Fig. 2) . In response to reduced barometric pressure, the lean rats abruptly reduced their food intake to 38% of the initial value (P Ͻ 0.01) during the first 24 h. Thereafter, food intake gradually increased to reach 70% of the rate of normoxic rats at day 4. Despite the absence of leptin signaling, the obese rats exposed to hypobaric VEGF, vascular endothelial growth factor; NPY, neuropeptide Y; POMC, proopiomelanocortin; CART, cocaine/amphetamine-related transcript; CRH, corticotropin-releasing hormone; AgRP, agouti-related protein. hypoxia also reduced their food intake, although less markedly than lean rats. At day 1 of exposure to hypoxia, the rate of food intake was 67% of the initial value (P Ͻ 0.01) in the obese group. This reduced rate of food intake was maintained during the whole period of exposure to hypoxia.
Body weight and adiposity. As expected from reduced food intake, a sharp drop in body weight (Ϫ6.5%, P Ͻ 0.001) was observed in lean rats after 1 day of exposure to hypobaric hypoxia (Fig. 3) . This was followed by a period of reduced weight gain. At day 4, the body weight of hypoxic lean rats remained 6% lower than their initial body weight (P Ͻ 0.001) and 22% lower than that of normoxic controls (P Ͻ 0.001). In the obese group, the drop in body weight at day 1 was of the same magnitude as in lean rats (Ϫ7%, P Ͻ 0.001). However, in contrast with the lean controls, obese rats rapidly recovered their normal rate of weight gain and reached their initial body weight by day 3.
The effect of hypoxia on adiposity was evaluated by weighing retroperitoneal adipose tissue in lean and obese rats ( Table  2 ). The absolute and relative weights of the retroperitoneal adipose tissue were higher in obese than in lean rats, as expected in this model of obesity. Whatever the genotype, changes of adipose tissue weight over the 4-day period of exposure to hypoxia failed to reach statistical significance.
Blood parameters. The blood parameters of normoxic rats were not statistically different after 1 or 4 days of experimental conditioning. Thus the data were combined to constitute control values (N group; Table 3 ). Circulating leptin levels did not increase over the 4 days of hypoxia exposure in the lean rats. Obese rats exhibited markedly higher plasma leptin concentrations (18-fold, P Ͻ 0.001) than lean animals, as previously reported in this animal model of leptin signaling deficiency. Moreover, circulating leptin levels abruptly increased twofold at day 1 and remained elevated in the obese rats exposed to hypoxia (P Ͻ 0.05). By contrast, hypoxia led to a gradual decrease in insulin levels in rats of both genotypes (global effect of hypoxia, P Ͻ 0.05), which reached statistical significance only in the obese rats (Ϫ29% at day 4, P Ͻ 0.05). There was a significant global effect of the genotype on blood glucose concentrations, with higher values in obese than in lean rats (P Ͻ 0.01), but no significant effect of hypoxia in rat of both genotypes.
Gene expression in adipose tissue.
In agreement with unchanged circulating leptin levels, leptin gene expression in the retroperitoneal adipose tissue was not significantly affected by hypobaric hypoxia in the lean rats (Table 4 ). In the obese group, leptin mRNA levels were markedly higher than in lean rats and increased markedly in response to hypoxia (P Ͻ 0.05). It is well established that VEGF is a hypoxia-inducible gene that is expressed in rat adipose tissue. Therefore, this gene was used here as a positive control of the occurrence of cellular hypoxia within adipose tissue. Similar to leptin mRNA, adipose VEGF mRNA levels were markedly higher in obese than in lean rats (main effect for genotype, P Ͻ 0.01). The obese rats exposed to hypoxia exhibited a gradual increase in VEGF Values are means Ϯ SE (n, no. of rats). *Significant difference between obese and lean Zucker rats, P Ͻ 0.05; †significant difference between H and N rats, P Ͻ 0.05. mRNA expression from day 2 to day 4. By contrast, a slight and not significant increase was observed in the lean group.
Neuropeptide expression in the hypothalamus. The expression of selected orexigenic and anorexigenic neuropeptides was measured in the hypothalamus of lean and obese rats (Table 5 ). Hypoxia significantly increased NPY mRNA levels in lean rats from day 2 to day 4 (P Ͻ 0.05), but no change was detected in the obese animals. Ambient hypoxia was without detectable effect on the expression of all other hypothalamic factors studied (POMC, CART, AgRP, and CRH) in either lean or obese rats.
DISCUSSION
The present study was designed to improve our limited information on the molecular mechanisms of hypoxia-induced anorexia. To our knowledge, this is the first investigation to explore directly the involvement of leptin in the anorexic response to acute hypobaric hypoxia through the use of a rat model of leptin resistance. Our data show that leptin receptordeficient (Lepr fa /Lepr fa ) Zucker rats exposed to hypobaric hypoxia displayed a pattern of food intake reduction closely similar to that of lean (Lepr FA /Lepr FA ) animals. Because obese Zucker rats are unable to respond to the effect of leptin (7, 16, 48, 49) , the present results establish unequivocally that altitude-induced anorexia cannot be ascribed to anorectic signals triggered by enhanced leptin production, at least after shortterm exposure to hypoxia. Acute exposure to low ambient oxygen is likely to be the major factor responsible for anorexia in the experimental system used here, since stress, known to produce a potent anorectic effect, was kept to a minimum, as confirmed by the absence of significant change in plasma corticosterone in hypoxic rats (data not shown).
Our initial hypothesis, based on a series of observations in cellular systems showing a stimulatory effect of hypoxia on leptin gene expression and secretion (2, (13) (14) (15) 23) was that exposure to hypoxia would increase circulating levels of leptin in the rats. This was not observed in nonobese rats exposed to a hypobaric environment for up to 4 days. By contrast, a marked and rapid rise in plasma leptin levels and a concurrent upregulation of leptin mRNA levels in adipose tissue occurred in obese rats in response to reduced barometric pressure. Interestingly, at variance with leptinemia, insulinemia tended to decrease in rats of both genotypes, demonstrating the specificity of the leptin response. Moreover, VEGF, a typical target gene of HIF-1-mediated transcription (43), followed the same pattern of regulation as leptin, as VEGF mRNA levels increased exclusively in the adipose tissue of obese rats. Thus, despite a similar hematological response to hypoxia in lean and obese rats, activation of two hypoxia target genes in the adipose tissue was apparent only in the obese rats. This genotype-associated differential sensitivity to hypoxia could be related to an increased hypoxic stimulus favored by the local hypoxic area in the hypertrophied adipose tissue of the obese rats. Alternatively, one possible explanation is that a counterregulation precludes leptin gene stimulation in the lean rats. It is established that hypoxia leads to an increase in neural sympathetic activity (38) . Several pieces of experimental evidence indicate that catecholamines inhibit leptin gene expression via ␤-adrenergic receptors (11, 19, 44) and that circulating leptin levels are reduced in response to situations, like cold exposure or fasting, which lead to sympathetic stimulation of white adipose tissue (37) . Thus enhanced sympathetic activity may overcome the specific effects of hypoxia on leptin production. The response of fat cells to catecholamines has been shown to be decreased in obese Zucker rats, mainly by alterations of the ␤-adrenergic signaling pathway (27) . This impairment could allow the stimulation of leptin gene expression under the hypoxic environment observed in white adipose tissue of obese animals.
Hypoxia is not the only stimulus that induces anorexia in the absence of leptin signaling. Administration of bacterial products, such as lipopolysaccharide (LPS), reduced food intake both in leptin receptor-deficient rodents and in leptin-sensitive controls (9, 24) . Similarly, we (12) have recently shown that obese Zucker rats decreased their spontaneous food intake in response to a systemic supply of calories from glucose. In that case, leptin-independent reduction in food intake was precluded by the inhibition of central acetyl-CoA carboxylase activity, suggesting the implication of anorectic signaling through malonyl-CoA (22) . Whether such a mechanism is activated in response to hypoxia is currently unknown. 
Values are means Ϯ SE (n, no. of rats). Amounts of neuropeptide mRNA are normalized to cyclophilin A as the housekeeping gene. Transcript values are expressed in %lean normoxic mean values. †Significant difference between H and N rats, whatever the genotype, P Ͻ 0.05. A downregulation of anabolic neuropeptides in the hypothalamus and/or an upregulation of catabolic signaling molecules was expected in response to acute exposure to hypoxia (42) . Our results clearly show that the main neuropeptide effectors of these pathways are not affected by acute hypoxia and cannot account for the initial drop in food intake in either lean or obese Zucker rats. It has been hypothesized that neurons located in the arcuate nucleus project into several hypothalamic areas, which are locations of second-order neuropeptide neurons involved in the regulation of food intake (41) . These neuropeptides include CRH, mainly involved in the activation of the hypothalamo-pituitary-adrenal axis, and known to inhibit energy intake (47) . We failed to show any significant change in CRH mRNA levels in the hypothalamus of hypoxic rats. This finding is consistent with the lack of alteration in hypothalamic CRH mRNA during the early development of neonatal rats exposed to hypoxia from birth (35) . Taken together, these results suggest that neither the main hypothalamic neuropeptides that regulate food intake nor the activity of the CRH system significantly contribute to explain the initial anorectic effect of ambient hypoxia.
Acute responses to weight loss are commonly bidirectional, including the activation of anabolic pathways and inhibition of catabolic pathways (42) . After an initial decrease in energy intake and substantial weight loss, there was a recovery of food consumption in lean rats exposed to hypoxia at day 2. This was accompanied by a significant increase in NPY gene expression in the hypothalamus, consistent with a response of anabolic pathways to rapid body weight loss. NPY is the more potent appetite-stimulating neuropeptide in mammals, eliciting a strong feeding response and decreasing energy expenditure (39) . However, this response of anabolic pathways remains incomplete, with a lack of increase in AgRP mRNA levels. Moreover, the catabolic pathways were not inhibited in this model, as suggested by unchanged POMC and CART transcripts in the hypothalamus of lean rats in response to hypoxiainduced weight loss. In the obese rats, the recovery of food consumption was faster than in lean animals and occurred with no detectable change in hypothalamic neuropeptide gene expression. At variance with lean rats, hypothalamic NPY mRNA was not increased in the obese rats. This suggests that, in absence of leptin signaling, a specific mechanism, which remains to be elucidated, rapidly induces food intake in response to weight loss. Monoaminergic neurotransmitters are also involved in food intake regulation in conjunction with neuropeptides (36) . Monoamines such as dopamine and serotonin affect hunger and satiety, and their contribution to explain the hypoxia-related appetite needs to be examined in future studies. Moreover, anorexia could result from alterations of the amount of food consumed during individual meals and/or from the frequency of meals. Meal size is controlled by satiety signals mainly initiated by mechanical and chemical stimulation of the stomach and the liver and humoral signals such as cholecystokinin (CCK) (10, 26) . A decrease in meal size with a rapid increase in satiety has been reported in humans during stays at altitude (52) , associated with a marked increase in plasma CCK. Further studies are needed to examine whether alterations in the production of this satiety peptide could account for the reduction of energy intake induced by acute exposure to hypoxia.
The present observations are relevant to the role played by leptin and several neuropeptides in alterations of food consumption after short-term responses to acute exposure to hypobaric hypoxia. Prolonged exposure to high altitude is associated with a negative energy balance mainly due to a reduction of energy intake (51, 52) . In humans, several factors that usually accompany high altitude, such as cold, stress, qualitatively or quantitatively limited food, and increased physical activity, can explain the decreased food consumption. However, recent studies clearly showed that hypoxia per se specifically depressed appetite (52), although energy intake increased slightly with acclimatization (50) . Of note, the decreased energy intake reported in populations born and living at high altitude cannot be attributed only to hypoxia, as socioeconomic status has been shown to markedly affect body weight and composition in these populations (32) . Even when food availability is sufficient, energy intake remains low at high altitude and body mass adapts to the new energy balance. Whether leptin signaling is involved in long-term adaptation to high altitude remains to be investigated.
In conclusion, by use of a rat model of leptin signaling deficiency, the present study demonstrates unequivocally that altitude-induced anorexia cannot be ascribed to anorectic signals triggered by enhanced leptin production. Moreover, the results show that anorexia induced by acute exposure to altitude is not driven by detectable alterations of hypothalamic neuropeptides involved in either anabolic or catabolic pathways. The present study provides new insights into the detrimental effects of oxygen deprivation on the nutritional status. Besides human subjects exposed to high altitude, chronic obstructive pulmonary disease patients are subjected to episodes of hypoxia, often associated with reduced food intake (5, 17) . The data presented here do not support a major role for increased leptin production in these symptoms, lowering the clinical relevance of a potential anti-leptin therapy.
